Corticosteroid-binding globulin

Corticosteroid-binding globulin (CBG), also known as transcortin, is a protein that is primarily involved in the transport of corticosteroids in the blood. It is a globulin protein that has a high affinity for cortisol, a type of hormone that plays a critical role in the body's response to stress. CBG is produced in the liver and is a key component in regulating the availability of cortisol to tissues and organs throughout the body.

Function

The primary function of corticosteroid-binding globulin is to bind and transport corticosteroids, especially cortisol, in the bloodstream. By binding to these hormones, CBG helps to regulate their availability and control their activity in the body. This regulation is crucial for maintaining homeostasis, particularly in response to stress and during the inflammatory response. CBG-bound cortisol is considered biologically inactive; only the free, unbound cortisol can enter cells and exert its effects. Therefore, CBG indirectly influences various physiological processes, including metabolism, immune response, and maintenance of blood pressure.

Structure

Corticosteroid-binding globulin is a glycoprotein, meaning it has carbohydrate groups attached to the polypeptide chain. This structure is essential for its function and stability in the bloodstream. The binding affinity of CBG for cortisol and other corticosteroids is influenced by its three-dimensional structure, which can be affected by genetic variations and external factors such as temperature and pH levels.

Regulation

The synthesis and secretion of CBG are regulated by several factors, including estrogens, which can increase CBG levels, and androgens, which have the opposite effect. This regulation can lead to variations in CBG levels among individuals and under different physiological conditions. For example, higher levels of CBG are observed during pregnancy due to increased estrogen levels.

Clinical Significance

Alterations in CBG levels or function can have significant clinical implications. Low levels of CBG can lead to an increase in free cortisol, potentially resulting in symptoms associated with Cushing's syndrome, while high levels of CBG can reduce the availability of free cortisol, mimicking symptoms of Addison's disease. Additionally, mutations in the gene encoding CBG can lead to rare conditions characterized by abnormal cortisol transport and metabolism.

Measurement

The measurement of CBG levels in the blood can be an important diagnostic tool in assessing adrenal function and diagnosing disorders related to cortisol imbalance. Various assays and techniques are used to measure CBG concentration and its binding capacity, providing valuable information for the diagnosis and management of endocrine disorders.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian